|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249.
2021.PubMed/NCBI
|
|
2
|
Wang J and Wu SG: Breast cancer: An
overview of current therapeutic strategies, challenges, and
perspectives. Breast Cancer (Dove Med Press). 15:721–730.
2023.PubMed/NCBI
|
|
3
|
Xiong X, Zheng LW, Ding Y, Chen YF, Cai
YW, Wang LP, Huang L, Liu CC, Shao ZM and Yu KD: Breast cancer:
Pathogenesis and treatments. Signal Transduct Target Ther.
10:492025. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Elía A, Saldain L, Vanzulli SI, Helguero
LA, Lamb CA, Fabris V, Pataccini G, Martínez-Vazquez P, Burruchaga
J, Caillet-Bois I, et al: Beneficial effects of mifepristone
treatment in patients with breast cancer selected by the
progesterone receptor isoform ratio: Results from the MIPRA trial.
Clin Cancer Res. 29:866–877. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Afifi N and Barrero CA: Understanding
breast cancer aggressiveness and its implications in diagnosis and
treatment. J Clin Med. 12:13752023. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dent R, Trudeau M, Pritchard KI, Hanna WM,
Kahn HK, Sawka CA, Lickley LA, Rawlinson E, Sun P and Narod SA:
Triple-negative breast cancer: Clinical features and patterns of
recurrence. Clin Cancer Res. 13:4429–4434. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kumar P and Aggarwal R: An overview of
triple-negative breast cancer. Arch Gynecol Obstet. 293:247–269.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lu Y, Liu H, Bi Y, Yang H, Li Y, Wang J,
Zhang Z, Wang Y, Li C, Jia A, et al: Glucocorticoid receptor
promotes the function of myeloid-derived suppressor cells by
suppressing HIF1α-dependent glycolysis. Cell Mol Immunol.
15:618–629. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hou Y, Xie J, Wang S, Li D, Wang L, Wang
H, Ni X, Leng S, Li G, Hou M and Peng J: Glucocorticoid receptor
modulates myeloid-derived suppressor cell function via
mitochondrial metabolism in immune thrombocytopenia. Cell Mol
Immunol. 19:764–776. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhao Y, Shen XF, Cao K, Ding J, Kang X,
Guan WX, Ding YT, Liu BR and Du JF: Dexamethasone-induced
myeloid-derived suppressor cells prolong allo cardiac graft
survival through iNOS- and glucocorticoid receptor-dependent
mechanism. Front Immunol. 9:2822018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li X, Chen J, Chen YJ, Qiao YD, Zhao LY,
Jiang N, Wu XY and Xing YF: Dexamethasone and lactoferrin induced
PMN-MDSCs relieved inflammatory adverse events of anti-cancer
therapy without tumor promotion. Commun Biol. 4:2522021. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Umansky V, Blattner C, Gebhardt C and
Utikal J: The role of myeloid-derived suppressor cells (MDSC) in
cancer progression. Vaccines (Basel). 4:362016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lasser SA, Ozbay Kurt FG, Arkhypov I,
Utikal J and Umansky V: Myeloid-derived suppressor cells in cancer
and cancer therapy. Nat Rev Clin Oncol. 21:147–164. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shou D, Wen L, Song Z, Yin J, Sun Q and
Gong W: Suppressive role of myeloid-derived suppressor cells
(MDSCs) in the microenvironment of breast cancer and targeted
immunotherapies. Oncotarget. 7:64505–64511. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Swildens KX, Sillevis Smitt PAE, van den
Bent MJ, French PJ and Geurts M: The effect of dexamethasone on the
microenvironment and efficacy of checkpoint inhibitors in
glioblastoma: A systematic review. Neurooncol Adv.
4:vdac0872022.PubMed/NCBI
|
|
16
|
Khadka S, Druffner SR, Duncan BC and
Busada JT: Glucocorticoid regulation of cancer development and
progression. Front Endocrinol (Lausanne). 14:11617682023.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tokunaga A, Sugiyama D, Maeda Y, Warner
AB, Panageas KS, Ito S, Togashi Y, Sakai C, Wolchok JD and
Nishikawa H: Selective inhibition of low-affinity memory
CD8+ T cells by corticosteroids. J Exp Med.
216:2701–2713. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Iorgulescu JB, Gokhale PC, Speranza MC,
Eschle BK, Poitras MJ, Wilkens MK, Soroko KM, Chhoeu C, Knott A,
Gao Y, et al: Concurrent dexamethasone limits the clinical benefit
of immune checkpoint blockade in glioblastoma. Clin Cancer Res.
27:276–287. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mohammad AS, Zina F and Jenna R: Cortisol
and breast cancer: A review of clinical and molecular evidence. Adv
Clin Res Ther. 26:19–25. 2018.
|
|
20
|
Sephton SE, Lush E, Dedert EA, Floyd AR,
Rebholz WN, Dhabhar FS, Spiegel D and Salmon P: Diurnal cortisol
rhythm as a predictor of lung cancer survival. Brain Behav Immun.
30 (Suppl):S163–S170. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mitre-Aguilar IB, Moreno-Mitre D,
Melendez-Zajgla J, Maldonado V, Jacobo-Herrera NJ, Ramirez-Gonzalez
V and Mendoza-Almanza G: The role of glucocorticoids in breast
cancer therapy. Curr Oncol. 30:298–314. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu R, Chen H, Zhao P, Chen CH, Liang H,
Yang C, Zhou Z, Zhi X, Liu S and Chen C: Mifepristone derivative
FZU-00,003 suppresses triple-negative breast cancer cell growth
partially via miR-153-KLF5 axis. Int J Biol Sci. 16:611–619. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu R, Shi P, Nie Z, Liang H, Zhou Z, Chen
W, Chen H, Dong C, Yang R, Liu S and Chen C: Mifepristone
suppresses basal triple-negative breast cancer stem cells by
down-regulating KLF5 expression. Theranostics. 6:533–544. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang X, Yao J, Li X, Niu N, Liu Y, Hajek
RA, Peng G, Westin S, Sood AK and Liu J: Targeting polyploid giant
cancer cells potentiates a therapeutic response and overcomes
resistance to PARP inhibitors in ovarian cancer. Sci Adv.
9:eadf71952023. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Langlois S, St-Pierre ME, Holland SH,
Xiang X, Freeman E, Mohamed H, Dural AC, Hammad A, Karami S, van de
Panne C and Cowan KN: Inhibition of PANX1 channels reduces the
malignant properties of human high-risk neuroblastoma. J Cancer.
14:689–706. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liao J, Wang X, Bi Y, Shen B, Shao K, Yang
H, Lu Y, Zhang Z, Chen X, Liu H, et al: Dexamethasone potentiates
myeloid-derived suppressor cell function in prolonging allograft
survival through nitric oxide. J Leukoc Biol. 96:675–684. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Waight JD, Hu Q, Miller A, Liu S and
Abrams SI: Tumor-derived G-CSF facilitates neoplastic growth
through a granulocytic myeloid-derived suppressor cell-dependent
mechanism. PLoS One. 6:e276902011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu L, Liu Y, Yan X, Zhou C and Xiong X:
The role of granulocyte colony-stimulating factor in breast cancer
development: A review. Mol Med Rep. 21:2019–2029. 2020.PubMed/NCBI
|
|
29
|
Swierczak A, Cook AD, Lenzo JC, Restall
CM, Doherty JP, Anderson RL and Hamilton JA: The promotion of
breast cancer metastasis caused by inhibition of CSF-1R/CSF-1
signaling is blocked by targeting the G-CSF receptor. Cancer
Immunol Res. 2:765–776. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Condamine T, Ramachandran I, Youn JI and
Gabrilovich DI: Regulation of tumor metastasis by myeloid-derived
suppressor cells. Annu Rev Med. 66:97–110. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Obradović MMS, Hamelin B, Manevski N,
Couto JP, Sethi A, Coissieux MM, Münst S, Okamoto R, Kohler H,
Schmidt A, et al: Glucocorticoids promote breast cancer metastasis.
Nature. 567:540–544. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ma W, Liu P, Zheng J, Lü J, Zhao Q, Li D,
Guo Y, Qian L, Wang Q, Miao X and Yu Z: Immune and nonimmune
mechanisms mediate the mental stress-induced tumor growth in a
xenograft model of breast cancer. Cell Death Dis. 12:9872021.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hamden JE, Salehzadeh M, Jalabert C,
O'Leary TP, Snyder JS, Gomez-Sanchez CE and Soma KK: Measurement of
11-dehydrocorticosterone in mice, rats and songbirds: Effects of
age, sex and stress. Gen Comp Endocrinol. 281:173–182. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Salehzadeh M, Hamden JE, Li MX, Bajaj H,
Wu RS and Soma KK: Glucocorticoid production in lymphoid organs:
Acute effects of lipopolysaccharide in neonatal and adult mice.
Endocrinology. 163:bqab2442022. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Morton NM, Paterson JM, Masuzaki H, Holmes
MC, Staels B, Fievet C, Walker BR, Flier JS, Mullins JJ and Seckl
JR: Novel adipose tissue-mediated resistance to diet-induced
visceral obesity in 11β-hydroxysteroid dehydrogenase type
1-deficient mice. Diabetes. 53:931–938. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Taves MD, Plumb AW, Sandkam BA, Ma C, Van
Der Gugten JG, Holmes DT, Close DA, Abraham N and Soma KK: Steroid
profiling reveals widespread local regulation of glucocorticoid
levels during mouse development. Endocrinology. 156:511–522. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Prasad Sakamuri SS, Sukapaka M, Prathipati
VK, Nemani H, Putcha UK, Pothana S, Koppala SR, Ponday LR, Acharya
V, Veetill GN and Ayyalasomayajula V: Carbenoxolone treatment
ameliorated metabolic syndrome in WNIN/Ob obese rats, but induced
severe fat loss and glucose intolerance in lean rats. PLoS One.
7:e502162012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Taves MD, Otsuka S, Taylor MA, Donahue KM,
Meyer TJ, Cam MC and Ashwell JD: Tumors produce glucocorticoids by
metabolite recycling, not synthesis, and activate Tregs to promote
growth. J Clin Invest. 133:e1645992023. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Deng Y, Xia X, Zhao Y, Zhao Z, Martinez C,
Yin W, Yao J, Hang Q, Wu W, Zhang J, et al: Glucocorticoid receptor
regulates PD-L1 and MHC-I in pancreatic cancer cells to promote
immune evasion and immunotherapy resistance. Nat Commun.
12:70412021. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Szebeni GJ, Alföldi R, Nagy LI, Neuperger
P, Gémes N, Balog JÁ, Tiszlavicz L and Puskás LG: Introduction of
an ultraviolet C-irradiated 4T1 murine breast cancer whole-cell
vaccine model. Vaccines (Basel). 11:12542023. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Chen C, Nong Z, Xie Q, He J, Cai W, Tang
X, Chen X, Huang R and Gao Y: 2-Dodecyl-6-methoxycyclohexa-2,
5-diene-1, 4-dione inhibits the growth and metastasis of breast
carcinoma in mice. Sci Rep. 27:67042017. View Article : Google Scholar : PubMed/NCBI
|
